Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical and Immunological Response Following hTERT/Survivin mRNA-Loaded Dendritic Cell Vaccination Combined With Ex-Vivo Expanded T Cell Transfer In Melanoma Patients

Gunnar Kvalheim, MD, PhD, Iris Bigalke, MD, Siri Torhaug, MD, Marianne Lundby, Camilla Mollat, Else-Marit Inderberg Suso, PhD, Arne Kolstad, MD, PhD, Gustav Gaudernack, PhD, Anne-Marie Rasmussen, PhD, Steinar Aamdal, MD, PhD

Blood (2013) 122 (21): 4487.

https://doi.org/10.1182/blood.V122.21.4487.4487

Published: 2013

Journal Articles

A Novel Cancer Vaccine Strategy In Previously Untreated Patients with Stage III/IV Follicular Lymphoma Generates Tumor-Reactive T Cells and Clinical Response

Arne Kolstad, MD, PhD, Shraddha Kumari, PhD, Gunnar Kvalheim, MD, PhD, Trond Velde Bogsrud, MD, PhD, Ulf Madsbu, MD, Trond Hagtvedt, MD, Gustav Gaudernack, MD, Grethe Lauvvang, RN, Harald Holte, MD, PhD, Johanna Olweus, MD, PhD

Blood (2010) 116 (21): 1804.

https://doi.org/10.1182/blood.V116.21.1804.1804

Published: 2010

Journal Articles

T Cell Responses in Patients Vaccinated with Telomerase (hTERT)-mRNA Transfected Dendritic Cells.

Else Marit Inderberg Suso, Phd, fellow, Anne-Marie Rasmussen, PhD, Steinar Aamdal, MD, PhD, Svein Dueland, MD, PhD, Gustav Gaudernack, PhD, Gunnar Kvalheim, MD, PhD

Blood (2009) 114 (22): 373.

https://doi.org/10.1182/blood.V114.22.373.373

Published: 2009

Journal Articles

Efficient Generation of Tumor-Specific, Cytotoxic T Cells by Genetic Transfer of allo-MHC.

Erlend Stronen, Ingerid Abrahamsen, MD, Finn-Eirik Johansen, PhD, Gustav Gaudernack, Fridtjof Lund-Johansen, MD, PhD, Johanna Olweus, MD, PhD

Blood (2007) 110 (11): 2755.

https://doi.org/10.1182/blood.V110.11.2755.2755

Published: 2007

Journal Articles

RNA Based Cancer Vaccines - Clinical Trials in Patients with Prostate Cancer and Malignant Melanoma.

Gunnar Kvalheim, MD, PhD, Steinar Aamdal, MD, PhD, Gustav Gaudernack, PhD

Blood (2007) 110 (11): 1805.

https://doi.org/10.1182/blood.V110.11.1805.1805

Published: 2007

NARROW

Clinical and Immunological Response Following hTERT/Survivin mRNA-Loaded Dendritic Cell Vaccination Combined With Ex-Vivo Expanded T Cell Transfer In Melanoma Patients

A Novel Cancer Vaccine Strategy In Previously Untreated Patients with Stage III/IV Follicular Lymphoma Generates Tumor-Reactive T Cells and Clinical Response

T Cell Responses in Patients Vaccinated with Telomerase (hTERT)-mRNA Transfected Dendritic Cells.

Efficient Generation of Tumor-Specific, Cytotoxic T Cells by Genetic Transfer of allo-MHC.

RNA Based Cancer Vaccines - Clinical Trials in Patients with Prostate Cancer and Malignant Melanoma.

Email alerts

ASH Publications

American Society of Hematology

Clinical and Immunological Response Following hTERT/Survivin mRNA-Loaded Dendritic Cell Vaccination Combined With Ex-Vivo Expanded T Cell Transfer In Melanoma Patients

A Novel Cancer Vaccine Strategy In Previously Untreated Patients with Stage III/IV Follicular Lymphoma Generates Tumor-Reactive T Cells and Clinical Response

T Cell Responses in Patients Vaccinated with Telomerase (hTERT)-mRNA Transfected Dendritic Cells.

Efficient Generation of Tumor-Specific, Cytotoxic T Cells by Genetic Transfer of allo-MHC.

RNA Based Cancer Vaccines - Clinical Trials in Patients with Prostate Cancer and Malignant Melanoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only